schliessen

Filtern

 

Bibliotheken

The German experience in reference pricing

Price regulation schemes function both as a means for public authorities to contain costs, and as an economic tool to support the national pharmaceutical industry. This twofold contradictory aim of public intervention in pharmaceutical demand and supply makes such pricing schemes difficult to apply.... Full description

Journal Title: Health policy 1998, Vol.44(1), pp.73-85
Main Author: Giuliani, Giovanni
Other Authors: Selke, Gisbert , Garattini, Livio
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: ISSN: 0168-8510 ; E-ISSN: 1872-6054 ; DOI: 10.1016/S0168-8510(98)00012-8
Link: https://www.sciencedirect.com/science/article/pii/S0168851098000128
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: elsevier_sdoi_10_1016_S0168_8510_98_00012_8
title: The German experience in reference pricing
format: Article
creator:
  • Giuliani, Giovanni
  • Selke, Gisbert
  • Garattini, Livio
subjects:
  • German Health Care System
  • Pharmaceutical Policy
  • Reference Pricing
  • Public Health
ispartof: Health policy, 1998, Vol.44(1), pp.73-85
description: Price regulation schemes function both as a means for public authorities to contain costs, and as an economic tool to support the national pharmaceutical industry. This twofold contradictory aim of public intervention in pharmaceutical demand and supply makes such pricing schemes difficult to apply. This article concerns the reference price scheme which concerns setting a price cap for each active ingredient, or group of active ingredients considered equivalent according to some feature (e.g. therapeutic effects and chemical structure). In 1989, the reference price scheme for reimbursable drugs was introduced in Germany to reduce pharmaceutical expenditure, which had been steadily increasing in the past. The study investigates the economic effects of introducing reference prices in Germany in order to assess whether this system has been effective in containing public pharmaceutical expenditure. We conclude that the reference price scheme is an effective tool for price control, but cost containment requires further measures.
language: eng
source:
identifier: ISSN: 0168-8510 ; E-ISSN: 1872-6054 ; DOI: 10.1016/S0168-8510(98)00012-8
fulltext: fulltext
issn:
  • 0168-8510
  • 01688510
  • 1872-6054
  • 18726054
url: Link


@attributes
ID529211581
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordiddoi_10_1016_S0168_8510_98_00012_8
sourceidelsevier_s
recordidTN_elsevier_sdoi_10_1016_S0168_8510_98_00012_8
sourcesystemPC
dbid
0--K
1--M
2.FO
3.~1
41B1
51P~
61RT
71~.
8457
94G.
107-5
118P~
129JM
13AABNK
14AAEDT
15AAKOC
16AAOAW
17AAQFI
18ABBQC
19ABMZM
20ABYKQ
21ACDAQ
22ACIUM
23ACRLP
24AEKER
25AEVXI
26AFKWA
27AFTJW
28AFXIZ
29AGHFR
30AGUBO
31AGYEJ
32AHHHB
33AIKHN
34AITUG
35AJBFU
36AJOXV
37AJRQY
38AJUYK
39AMFUW
40ANZVX
41BLXMC
42BNPGV
43EO8
44EO9
45EP2
46EP3
47FDB
48FGOYB
49FIRID
50FNPLU
51G-Q
52GBLVA
53HEH
54HMK
55HMO
56J1W
57KOM
58LCYCR
59OAUVE
60P-8
61P-9
62PC.
63Q38
64R2-
65RPZ
66SAE
67SCC
68SDF
69SDG
70SDP
71SEL
72SES
73SEW
74SSH
75SSZ
76T5K
77Z5R
78~G-
pqid79951699
display
typearticle
titleThe German experience in reference pricing
creatorGiuliani, Giovanni ; Selke, Gisbert ; Garattini, Livio
ispartofHealth policy, 1998, Vol.44(1), pp.73-85
identifier
subjectGerman Health Care System ; Pharmaceutical Policy ; Reference Pricing ; Public Health
languageeng
source
descriptionPrice regulation schemes function both as a means for public authorities to contain costs, and as an economic tool to support the national pharmaceutical industry. This twofold contradictory aim of public intervention in pharmaceutical demand and supply makes such pricing schemes difficult to apply. This article concerns the reference price scheme which concerns setting a price cap for each active ingredient, or group of active ingredients considered equivalent according to some feature (e.g. therapeutic effects and chemical structure). In 1989, the reference price scheme for reimbursable drugs was introduced in Germany to reduce pharmaceutical expenditure, which had been steadily increasing in the past. The study investigates the economic effects of introducing reference prices in Germany in order to assess whether this system has been effective in containing public pharmaceutical expenditure. We conclude that the reference price scheme is an effective tool for price control, but cost containment requires further measures.
version5
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
backlink$$Uhttps://www.sciencedirect.com/science/article/pii/S0168851098000128$$EView_record_in_ScienceDirect_(Access_to_full_text_may_be_restricted)
search
creatorcontrib
0Giuliani, Giovanni
1Selke, Gisbert
2Garattini, Livio
titleThe German experience in reference pricing
subject
0German Health Care System
1Pharmaceutical Policy
2Reference Pricing
3Public Health
general
0English
1Elsevier Ireland Ltd
210.1016/S0168-8510(98)00012-8
3ScienceDirect (Elsevier)
4ScienceDirect Journals (Elsevier)
sourceidelsevier_s
recordidelsevier_sdoi_10_1016_S0168_8510_98_00012_8
issn
00168-8510
101688510
21872-6054
318726054
rsrctypearticle
creationdate1998
addtitleHealth policy
searchscope
0elsevier_full
1elsevier2
scope
0elsevier_full
1elsevier2
lsr44$$EView_record_in_ScienceDirect_(Access_to_full_text_may_be_restricted)
tmp01ScienceDirect Journals (Elsevier)
tmp02
0--K
1--M
2.FO
3.~1
41B1
51P~
61RT
71~.
8457
94G.
107-5
118P~
129JM
13AABNK
14AAEDT
15AAKOC
16AAOAW
17AAQFI
18ABBQC
19ABMZM
20ABYKQ
21ACDAQ
22ACIUM
23ACRLP
24AEKER
25AEVXI
26AFKWA
27AFTJW
28AFXIZ
29AGHFR
30AGUBO
31AGYEJ
32AHHHB
33AIKHN
34AITUG
35AJBFU
36AJOXV
37AJRQY
38AJUYK
39AMFUW
40ANZVX
41BLXMC
42BNPGV
43EO8
44EO9
45EP2
46EP3
47FDB
48FGOYB
49FIRID
50FNPLU
51G-Q
52GBLVA
53HEH
54HMK
55HMO
56J1W
57KOM
58LCYCR
59OAUVE
60P-8
61P-9
62PC.
63Q38
64R2-
65RPZ
66SAE
67SCC
68SDF
69SDG
70SDP
71SEL
72SES
73SEW
74SSH
75SSZ
76T5K
77Z5R
78~G-
startdate19980101
enddate19981231
lsr40Health policy, 1998, Vol.44 (1), pp.73-85
doi10.1016/S0168-8510(98)00012-8
citationpf 73 pt 85 vol 44 issue 1
lsr30VSR-Enriched:[pqid, description]
sort
titleThe German experience in reference pricing
authorGiuliani, Giovanni ; Selke, Gisbert ; Garattini, Livio
creationdate19980000
lso0119980000
facets
frbrgroupid6880133173523928437
frbrtype5
newrecords20190904
languageeng
topic
0German Health Care System
1Pharmaceutical Policy
2Reference Pricing
3Public Health
collectionScienceDirect (Elsevier)
prefilterarticles
rsrctypearticles
creatorcontrib
0Giuliani, Giovanni
1Selke, Gisbert
2Garattini, Livio
jtitleHealth policy
creationdate1998
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
aulast
0Giuliani
1Selke
2Garattini
aufirst
0Giovanni
1Gisbert
2Livio
auinitG
auinit1G
au
0Giuliani, Giovanni
1Selke, Gisbert
2Garattini, Livio
atitleThe German experience in reference pricing
jtitleHealth policy
date1998
risdate1998
volume44
issue1
spage73
epage85
pages73-85
issn0168-8510
eissn1872-6054
formatjournal
genrearticle
ristypeJOUR
pubElsevier Ireland Ltd
doi10.1016/S0168-8510(98)00012-8
lad01Health policy